Cumulative effect of metabolic syndrome on the risk of retinal vein occlusion in young patients: A nationwide population-based study.
Yeji KimChul Gu KimJong Woo KimKyungdo HanJae Hui KimPublished in: PloS one (2024)
This study aimed to investigate the impact of the cumulative burden of metabolic syndrome (MetS) on the incidence of retinal vein occlusion (RVO) in young adults. We included 1,408,093 subjects aged ≥20 and <40 years without a history of RVO who underwent four consecutive annual health examinations during 2009-2012 from the database of the Korean National Health Insurance Service. The metabolic burden was evaluated based on the cumulative number of MetS diagnoses at each health examination (0-4 times) and the cumulative number of each MetS component diagnosed at each health examination (0-4 times per MetS component). Cox proportional hazards models were used to estimate the risk of RVO according to metabolic burden. The risk of RVO was positively correlated with the cumulative number of MetS diagnoses over the four health examinations. All five MetS components were independently associated with an increased risk of RVO. Subgroup analysis for the impact of MetS on RVO occurrence revealed that MetS had a greater impact on female subjects (P <0.001). Prompt detection of metabolic derangements and their treatment might be important to decrease the risk of RVO in young adults, especially women.
Keyphrases
- healthcare
- metabolic syndrome
- young adults
- public health
- mental health
- health insurance
- health information
- risk factors
- end stage renal disease
- chronic kidney disease
- diabetic retinopathy
- newly diagnosed
- insulin resistance
- risk assessment
- randomized controlled trial
- emergency department
- adipose tissue
- ejection fraction
- quality improvement
- cardiovascular disease
- pregnant women
- health promotion
- prognostic factors
- skeletal muscle
- clinical trial
- single cell
- cardiovascular risk factors
- social media
- electronic health record
- drug induced
- open label
- adverse drug